<DOC>
	<DOCNO>NCT01106547</DOCNO>
	<brief_summary>The purpose study evaluate effect 125 mg methylprednisolone , give intravenously 60-90 minute abdominal surgery , postoperative rehabilitation abdominal hysterectomy.Sodium Chloride placebo . The following parameter register : 1 . Pain 3 , 6 24 hour postoperatively 2-7 day surgery . 2 . The postoperative use additional analgesic . 3 . Inflammatory parameter surgery . 4 . Time mobilization . 5 . Time discharge .</brief_summary>
	<brief_title>The Effect Preoperative Single-dose Methylprednisolone Postoperative Rehabilitation After Abdominal Hysterectomy</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Patients abdominal hysterectomy benign indication . Patients speak understand Danish . Patients give informed consent . Diabetics Regular use glucocorticoid , opioids tranquilizer Regular treatment immunosuppressive Alcohol drug abuse Morphine intolerance Age 18 Chronic pain disease eg fibromyalgia , rheumatoid arthritis Malign indication hysterectomy BMI 35 Decreased kidney function ASA III IV</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>abdominal hysterectomy</keyword>
	<keyword>glucocorticoid</keyword>
	<keyword>rehabilitation</keyword>
	<keyword>postoperative pain</keyword>
	<keyword>analgetics</keyword>
</DOC>